The current study, as well as recent work by our group (Kakalij et al., 2022) and others (Hanna Kazazian et al., 2019; Revelo et al., 2016) suggest that enhanced TLR7 activation may exacerbate the development of MetS features, including impaired glucose homeostasis and insulin resistance. Here, TLR7 is linked to metabolic syndrome.